Sodium oxybate for the treatment of fibromyalgia

Bibliography

• Vickers MD. Gamma hydroxybutyric acid. Clinical pharmacology and current status. Proc R Soc Med 1968;61:821-4
   PubMedGoogle Scholar
• Snead OC. Evidence for a G protein-coupled gamma-hydroxybutyric acid receptor. J Neurochem 2000;75:1986-96
   PubMed Web of Science ®Google Scholar
• Hu RQ, Banerjee PK, Snead OC. Regulation of gamma-aminobutyric acid (GABA) release in cerebral cortex in the gamma-hydroxybutyric acid (GHB) model of absence seizures in rat. Neuropharmacology 2000;39:427-39
   PubMed Web of Science ®Google Scholar
• Snead OC, Gibson KM. Gamma-hydroxybutyric acid. N Engl J Med 2005;352:2721-32
   PubMed Web of Science ®Google Scholar
• Cash CD, Gobaille S, Kemmel V, Gamma-hydroxybutyrate receptor function studied by the modulation of nitric oxide synthase activity in rat frontal cortex punches. Biochem Pharmacol 1999;58:1815-9
   PubMed Web of Science ®Google Scholar
• Spitzer AR, Broadman M. A retrospective review of the sleep characteristics in patients with chronic fatigue syndrome and fibromyalgia. Pain Pract 2010;10:294-300
   PubMed Web of Science ®Google Scholar
• Wolfe F, Ross K, Erson J, The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 1995;38:19-28
   PubMed Web of Science ®Google Scholar
• Scharf MB, Baumann M, Berkowitz DV. The effects of sodium oxybate on clinical symptoms and sleep patterns in patients with fibromyalgia. J Rheumatol 2003;30:1070-4
   PubMed Web of Science ®Google Scholar
• Maitre M. The gamma-hydroxybutyrate signalling system in brain: organization and functional implications. Prog Neurobiol 1997;51:337-61
   PubMed Web of Science ®Google Scholar
• Pardi D, Black J. Gamma-Hydroxybutyrate/sodium oxybate – Neurobiology and impact on sleep and wakefulness. CNS Drugs 2006;20:993-1018
   PubMed Web of Science ®Google Scholar
• Robinson DM, Keating GM. Sodium oxybate: a review of its use in the management of narcolepsy. CNS Drugs 2007;21:337-54
   PubMed Web of Science ®Google Scholar
• Broughton R, Mamelak M. The treatment of narcolepsy-cataplexy with nocturnal gamma-hydroxybutyrate. Can J Neurol Sci 1979;6:1-6
   PubMed Web of Science ®Google Scholar
• Saitz R, O'Malley SS. Pharmacotherapies for alcohol abuse. Withdrawal and treatment. Med Clin North Am 1997;81:881-907
   PubMed Web of Science ®Google Scholar
• Leone MA, Vigna-Taglianti F, Avanzi G, Gamma-hydroxybutyrate (GHB) for treatment of alcohol withdrawal and prevention of relapses. Cochrane Database Syst Rev 2010:CD006266
   PubMed Web of Science ®Google Scholar
• Wedin GP, Hornfeldt CS, Ylitalo LM. The clinical development of gamma-hydroxybutyrate (GHB). Curr Drug Saf 2006;1:99-106
   PubMedGoogle Scholar
• Laborit H. Correlations between protein and serotonin synthesis during various activities of the central nervous system (slow and desynchronized sleep, learning and memory, sexual activity, morphine tolerance, aggressiveness and pharmacological action of sodium gamma-hydroxybutyrate). Res Commun Chem Pathol Pharmacol 1972;3:51-81
   PubMedGoogle Scholar
• Rigamonti AE, Muller EE. Gamma-hydroxybutyric acid and growth hormone secretion studies in rats and dogs. Alcohol 2000;20:293-304
   PubMed Web of Science ®Google Scholar
• Takahara J, Yunoki S, Yakushiji W, Stimulatory effects of gamma-hydroxybutyric acid on growth hormone and prolactin release in humans. J Clin Endocrinol Metab 1977;44:1014-17
   PubMed Web of Science ®Google Scholar
• Nicholson KL, Balster RL. GHB: a new and novel drug of abuse. Drug Alcohol Depend 2001;63:1-22
   PubMed Web of Science ®Google Scholar
• Rodgers J, Ashton CH, Gilvarry E, Young AH. Liquid ecstasy: a new kid on the dance floor. Br J Psychiatry 2004;184:104-6
   PubMed Web of Science ®Google Scholar
• Nemeth Z, Kun B, Demetrovics Z. The involvement of gamma-hydroxybutyrate in reported sexual assaults: a systematic review. J Psychopharmacol 2010;24:1281-7
   PubMed Web of Science ®Google Scholar
• Weiss KG, Colyer CJ. Roofies, mickies and cautionary tales: examining the persistence of the "Date-Rape-Drug" crime narrative. Deviant Behavior 2010;31:348-79
   Web of Science ®Google Scholar
• Cash CD. Gamma-hydroxybutyrate: an overview of the pros and cons for it being a neurotransmitter and/or a useful therapeutic agent. Neurosci Biobehav Rev 1994;18:291-304
   PubMed Web of Science ®Google Scholar
• Hechler V, Peter P, Gobaille S, Gamma-Hydroxybutyrate ligands possess antidopaminergic and neuroleptic-like activities. J Pharmacol Exp Ther 1993;264:1406-14
   PubMed Web of Science ®Google Scholar
• Gobaille S, Schleef C, Hechler V, Gamma-hydroxybutyrate increases tryptophan availability and potentiates serotonin turnover in rat brain. Life Sci 2002;70:2101-12
   PubMed Web of Science ®Google Scholar
• Szabo ST, Gold MS, Goldberger BA, Blier P. Effects of sustained gamma-hydroxybutyrate treatments on spontaneous and evoked firing activity of locus coeruleus norepinephrine neurons. Biol Psychiatry 2004;55:934-9
   PubMedGoogle Scholar
• Gerra G, Caccavari R, Fontanesi B, Flumazenil effects on growth hormone response to gamma-hydroxybutyric acid. Int Clin Psychopharmacol 1994;9:211-15
   PubMed Web of Science ®Google Scholar
• Carter LP, Richards BD, Mintzer MZ, Griffiths RR. Relative abuse liability of GHB in humans: a comparison of psychomotor, subjective and cognitive effects of supratherapeutic doses of triazolam, pentobarbital and GHB. Neuropsychopharmacology 2006;31:2537-51
   PubMedGoogle Scholar
• Carter LP, Pardi D, Gorsline J, Griffiths RR. Illicit gamma-hydroxybutyrate (GHB) and pharmaceutical sodium oxybate (Xyrem): differences in characteristics and misuse. Drug Alcohol Depend 2009;104:1-10
   PubMed Web of Science ®Google Scholar
• Carter LP, Koek W, France CP. Behavioral analyses of GHB: receptor mechanisms. Pharmacol Ther 2009;121:100-14
   PubMed Web of Science ®Google Scholar
• Abanades S, Farre M, Segura M, Gamma-hydroxybutyrate (GHB) in humans: pharmacodynamics and pharmacokinetics. Ann NY Acad Sci 2006;1074:559-76
   PubMed Web of Science ®Google Scholar
• Chase TN, Murphy DL. Serotonin and central nervous system function. Annu Rev Pharmacol 1973;13:181-97
   PubMedGoogle Scholar
• Oreland L, Nordquist N, Hallman J, Environment and the serotonergic system. Eur Psychiatry 2010;25:304-6
   PubMedGoogle Scholar
• Borbely AA, Tobler I. Endogenous sleep-promoting substances and sleep regulation. Physiol Rev 1989;69:605-70
   PubMed Web of Science ®Google Scholar
• Portas CM, Bjorvatn B, Ursin R. Serotonin and the sleep/wake cycle: special emphasis on microdialysis studies. Prog Neurobiol 2000;60:13-35
   PubMed Web of Science ®Google Scholar
• Fields HL, Heinricher MM, Mason P. Neurotransmitters in nociceptive modulatory circuits. Annu Rev Neurosci 1991;14:219-45
   PubMed Web of Science ®Google Scholar
• Pompili M, Serafini G, Innamorati M, The hypothalamic-pituitary-adrenal axis and serotonin abnormalities: a selective overview for the implications of suicide prevention. Eur Arch Psychiatry Clin Neurosci 2010;260:583-600
   PubMed Web of Science ®Google Scholar
• Fang BJ, Tonelli LH, Soriano JJ, Postolache TT. Disturbed sleep: linking allergic rhinitis, mood and suicidal behavior. Front Biosci (Schol Ed) 2010;2:30-46
   PubMedGoogle Scholar
• Atkinson JH, Slater MA, Wahlgren DR, Effects of noradrenergic and serotonergic antidepressants on chronic low back pain intensity. Pain 1999;83:137-45
   PubMed Web of Science ®Google Scholar
• Skljarevski V, Desaiah D, Liu-Seifert H, Efficacy and safety of duloxetine in patients with chronic low back pain. Spine 2010;35:E578-85
   Web of Science ®Google Scholar
• Manabe N, Wong BS, Camilleri M. New-generation 5-HT4 receptor agonists: potential for treatment of gastrointestinal motility disorders. Expert Opin Investig Drugs 2010;19:765-75
   PubMed Web of Science ®Google Scholar
• Friedrich M, Grady SE, Wall GC. Effects of antidepressants in patients with irritable bowel syndrome and comorbid depression. Clin Ther 2010;32:1221-33
   PubMedGoogle Scholar
• Mease PJ. Further strategies for treating fibromyalgia: the role of serotonin and norepinephrine reuptake inhibitors. Am J Med 2009;122:S44-55
   Google Scholar
• Ciobica A, Hritcu L, Padurariu M, Effects of serotonin depletion on behavior and neuronal oxidative stress status in rat: relevance for anxiety and affective disorders. Adv Med Sci 2010;55:289-96
   PubMed Web of Science ®Google Scholar
• Supornsilpchai W, Sanguanrangsirikul S, Maneesri S, Srikiatkhachorn A. Serotonin depletion, cortical spreading depression and trigeminal nociception. Headache 2006;46:34-9
   PubMed Web of Science ®Google Scholar
• Cremata VY Jr, Koe BK. Clinical-pharmacological evaluation of p-chlorophenylalanine: a new serotonin-depleting agent. Clin Pharmacol Ther 1966;7:768-76
   PubMedGoogle Scholar
• Nishino S, Sagawa Y. The neurochemistry of awakening: findings from sleep disorder narcolepsy. Int Rev Neurobiol 2010;93:229-55
   PubMed Web of Science ®Google Scholar
• Murillo-Rodriguez E, Rias-Carrion O, Sanguino-Rodriguez K, Mechanisms of sleep-wake cycle modulation. CNS Neurol Disord Drug Targets 2009;8:245-53
   PubMed Web of Science ®Google Scholar
• Murphy PJ, Campbell SS. Physiology of the circadian system in animals and humans. J Clin Neurophysiol 1996;13:2-16
   PubMed Web of Science ®Google Scholar
• Campbell SS, Murphy PJ, Van Den Heuvel CJ, Etiology and treatment of intrinsic circadian rhythm sleep disorders. Sleep Med Rev 1999;3:179-200
   PubMed Web of Science ®Google Scholar
• Garcia-Garcia F, Drucker-Colin R. Endogenous and exogenous factors on sleep-wake cycle regulation. Prog Neurobiol 1999;58:297-314
   PubMed Web of Science ®Google Scholar
• Garcia-Garcia F, Costa-Pena E, Venebra-Munoz A, Murillo-Rodriguez E. Sleep-inducing factors. CNS Neurol Disord Drug Targets 2009;8:235-44
   PubMed Web of Science ®Google Scholar
• Wolfe F, Clauw DJ, Fitzcharles MA, The American College of rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res 2010;62:600-10
   PubMed Web of Science ®Google Scholar
• Bennett RM, Jones J, Turk DC, An internet survey of 2,596 people with fibromyalgia. BMC Musculoskeletal Disord 2007;8:1-11
   PubMedGoogle Scholar
• Choy E, Perrot S, Leon T, A patient survey of the impact of fibromyalgia and the journey to diagnosis. BMC Health Services Res 2010;10:102-11
   PubMed Web of Science ®Google Scholar
• Affleck G, Urrows S, Tennen H, Sequential daily relations of sleep, pain intensity and attention to pain among women with fibromyalgia. Pain 1996;68:363-8
   PubMed Web of Science ®Google Scholar
• Bigatti SM, Hernandez AM, Cronan TA, Rand KL. Sleep disturbances an fibromyalgia syndrome: relationship to pain and depression. Arthritis Rheum Arthritis Care Res 2008;59:961-7
   Web of Science ®Google Scholar
• Hauser W, Zimmer C, Felde E, Kollner V. What are the key symptoms of fibromyalgia? Schmerz 2008;22:176-83
   PubMed Web of Science ®Google Scholar
• Drewes AM, Gade K, Nielsen KD, Clustering of sleep electroencephalographic patterns in patients with the fibromyalgia syndrome. Br J Rheumatol 1995;34:1151-6
   PubMedGoogle Scholar
• Roizenblatt S, Moldofsky H, Benedito-Silva AA, Tufik S. Alpha sleep characteristics in fibromyalgia. Arthritis Rheum 2001;44:222-30
   PubMed Web of Science ®Google Scholar
• Branco J, Atalaia A, Paiva T. Sleep cycles and alpha-delta sleep in fibromyalgia syndrome. J Rheumatol 1994;21:1113-17
   PubMed Web of Science ®Google Scholar
• Moldofsky H, Scarisbrick P, England R, Smythe H. Musculosketal symptoms and non-REM sleep disturbance in patients with “fibrositis syndrome” and healthy subjects. Psychosom Med 1975;37:341-51
   PubMed Web of Science ®Google Scholar
• Moldofsky H. The significance of the sleeping-waking brain for the understanding of widespread musculoskeletal pain and fatigue in fibromyalgia syndrome and allied syndromes. Joint Bone Spine 2008;75:397-402
   PubMed Web of Science ®Google Scholar
• Anch AM, Lue FA, Maclean AW, Moldofsky H. Sleep physiology and psychological aspects of the fibrositis (fibromyalgia) syndrome. Can J Psychol 1991;45:179-84
   PubMed Web of Science ®Google Scholar
• Landis CA, Lentz MJ, Rothermel J, Decreased sleep spindles and spindle activity in midlife women with fibromyalgia and pain. Sleep 2004;27:741-50
   PubMed Web of Science ®Google Scholar
• Burns JW, Crofford LJ, Chervin RD. Sleep stage dynamics in fibromyalgia patients and controls. Sleep Med 2008;9:689-96
   PubMed Web of Science ®Google Scholar
• Rizzi M, Sarzi-Puttini P, Atzeni F, Cyclic alternating pattern: a new marker of sleep alteration in patients with fibromyalgia? J Rheumatol 2004;31:1193-9
   PubMed Web of Science ®Google Scholar
• Hicks RA, Coleman DD, Ferrante F, Pain thresholds in rats during recovery from REM sleep deprivation. Percept Mot Skills 1979;48:687-90
   PubMed Web of Science ®Google Scholar
• Hakki Onen S, Alloui A, Jourdan D, Effects of rapid eye movement (REM) sleep deprivation on pain sensitivity in the rat. Brain Res 2001;900:261-7
   PubMed Web of Science ®Google Scholar
• Moldofsky H, Scarisbrick P. Induction of neurasthenic musculoskeletal pain syndrome by selective sleep stage deprivation. Psychosom Med 1976;38:35-44
   PubMed Web of Science ®Google Scholar
• Older SA, Battafarano DF, Danning CL, The effects of delta wave sleep interruption on pain thresholds and fibromyalgia-like symptoms in healthy subjects; correlations with insulin-like growth factor I. J Rheumatol 1998;25:1180-6
   PubMed Web of Science ®Google Scholar
• Lentz MJ, Landis CA, Rothermel J, Shaver JL. Effects of selective slow wave sleep disruption on musculoskeletal pain and fatigue in middle aged women. J Rheumatol 1999;26:1586-92
   PubMed Web of Science ®Google Scholar
• Onen SH, Alloui A, Gross A, The effects of total sleep deprivation, selective sleep interruption and sleep recovery on pain tolerance thresholds in healthy subjects. J Sleep Res 2001;10:35-42
   PubMed Web of Science ®Google Scholar
• Kundermann B, Spernal J, Huber MT, Sleep deprivation affects thermal pain thresholds but not somatosensory thresholds in healthy volunteers. Psychosom Med 2004;66:932-7
   PubMed Web of Science ®Google Scholar
• Roehrs T, Hyde M, Blaisdell B, Sleep loss and REM sleep loss are hyperalgesic. Sleep 2006;29:145-51
   PubMed Web of Science ®Google Scholar
• Smith MT, Edwards RR, McCann UD, Haythornthwaite J. The effects of sleep deprivation on pain inhibition and spontaneous pain in women. Sleep 2007;30:494-505
   PubMed Web of Science ®Google Scholar
• Kundermann B, Krieg JC, Schreiber W, Lautenbacher S. The effect of sleep deprivation on pain. Pain Res Manag 2004;9:25-32
   PubMedGoogle Scholar
• Lautenbacher S, Kundermann B, Krieg JC. Sleep deprivation and pain perception. Sleep Med Rev 2006;10:357-69
   PubMed Web of Science ®Google Scholar
• Sullivan SS. Insomnia pharmacology. Med Clin North Am 2010;94:563-80
   PubMed Web of Science ®Google Scholar
• Kales A, Kales JD. Sleep disorders. Recent findings in the diagnosis and treatment of disturbed sleep. N Engl J Med 1974;290:487-99
   PubMed Web of Science ®Google Scholar
• Zammit G. Comparative tolerability of newer agents for insomnia. Drug Saf 2009;32:735-48
   PubMed Web of Science ®Google Scholar
• Reynolds WJ, Moldofsky H, Saskin P, Lue FA. The effects of cyclobenzaprine on sleep physiology and symptoms in patients with fibromyalgia. J Rheumatol 1991;18:452-4
   PubMed Web of Science ®Google Scholar
• Carette S, Oakson G, Guimont C, Steriade M. Sleep electroencephalography and the clinical response to amitriptyline in patients with fibromyalgia. Arthritis Rheum 1995;38:1211-7
   PubMed Web of Science ®Google Scholar
• Drewes AM, Reasen A, Jennum P, Nielsen KD. Zopiclone in the treatment of sleep abnormalities in fibromyalgia. Scand J Rheumatol 1991;20:288-93
   PubMed Web of Science ®Google Scholar
• Moldofsky H, Lue FA, Mously C, The effect of zolpidem in patients with fibromyalgia: a dose ranging, double blind, placebo controlled, modified crossover study [see comments]. J Rheumatol 1996;23:529-33
   PubMed Web of Science ®Google Scholar
• Saletu B, Prause W, Erer P, Insomnia in somatoform pain disorder: sleep laboratory studies on differences to controls and acute effects of trazodone, evaluated by the Somnolyzer 24 x 7 and the Siesta database. Neuropsychobiology 2005;51:148-63
   PubMed Web of Science ®Google Scholar
• Zavesicka L, Brunovsky M, Horacek J, Trazodone improves the results of cognitive behaviour therapy of primary insomnia in non-depressed patients. Neuro Endocrinol Lett 2008;29:895-901
   PubMedGoogle Scholar
• Smeyatsky N, Baldwin D, Botros W, The treatment of sleep disorders. S Afr Med J 1992;(suppl):1-8
   Google Scholar
• Hauser W, Bernardy K, Uceyler N, Sommer C. Treatment of fibromyalgia syndrome with antidepressants A meta-analysis. JAMA 2009;301:198-209
   PubMed Web of Science ®Google Scholar
• Ware MA, Fitzcharles MA, Joseph L, Shir Y. The effects of nabilone on sleep in fibromyalgia: results of a randomized controlled trial. Anesth Analg 2010;110:604-10
   PubMed Web of Science ®Google Scholar
• Moldofsky H, Inhaber NH, Guinta DR, Alvarez-Horine SB. Effects of sodium oxybate on sleep physiology and sleep/wake-related symptoms in patients with fibromyalgia syndrome: a double-blind, randomized, placebo-controlled study. J Rheumatol 2010;37:2156-66
   PubMed Web of Science ®Google Scholar
• Russell IJ, Perkins AT, Michalek JE. Sodium oxybate relieves pain and improves function in fibromyalgia syndrome: a randomized, double-blind, placebo-controlled, multicenter clinical trial. Arthritis Rheum 2009;60:299-309
   PubMed Web of Science ®Google Scholar
• Russell IJ, Holman AJ, Swick TJ, Sodium oxybate reduces pain, fatigue and sleep disturbance and improves functionality in fibromyalgia: results from a 14-week, randomized, double-blind, placebo-controlled study. Pain 2011;152:1007-17
   PubMed Web of Science ®Google Scholar
• Swick TJ, Alvarez-Horine S, Zheng Y, Sodium oxybate improves pain, fatigue and sleep in fibromyalgia: Results from a 14 week randomized, double-blind, placebo-controlled trial. Sleep 2009;32:A321
   Google Scholar
• Hauser W, Petzke F, Sommer C. Comparative efficacy and harms of duloxetine, milnacipran and pregabalin in fibromyalgia syndrome. J Pain 2010;11:505-21
   PubMed Web of Science ®Google Scholar
• Bjordal JM, Johnson MI, Lopes-Martins RA, Short-term efficacy of physical interventions in osteoarthritic knee pain. A systematic review and meta-analysis of randomised placebo-controlled trials. BMC Musculoskelet Disord 2007;8:51
   PubMed Web of Science ®Google Scholar
• Kroenke K, Krebs EE, Bair MJ. Pharmacotherapy of chronic pain: a synthesis of recommendations from systematic reviews. Gen Hosp Psychiatry 2009;31:206-19
   PubMed Web of Science ®Google Scholar